...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients
【24h】

8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients

机译:8-Oxo-7,8-二氢鸟嘌呤和尿酸是结肠癌患者生存的有效预测指标

获取原文
获取原文并翻译 | 示例

摘要

The aim of this work was to answer the question whether the broad range of parameters which describe oxidative stress and oxidatively damaged DNA and repair are appropriate prognosis factors of colon cancer (CRC) patients survival? The following parameters were analyzed for 89 CRC patients: concentration of uric acid and vitamins A, E, C in plasma; levels of 8-oxodGuo (8-oxo-7,8-dihydro-2'-deoxyguanosine) in DNA of leukocyte and colon tissues; urinary excretion rates of 8-oxodGuo and 8-oxoGua (8-oxo-7,8-dihydroguanine); the activity and mRNA or protein level of repair enzymes OGG1, APE1, ANPG, TDG and PARP1. All DNA modifications and plasma antioxidants were analyzed using high performance liquid chromatography (HPLC) or HPLC/gas chromatography-mass spectrometry techniques. Expression of repair proteins was analyzed by QPCR, Western or immunohistochemistry methods. Longer survival coincided with low levels of 8-oxodGuo/8oxoGua in urine and 8-oxodGuo in DNA as well as with high concentration of uric acid plasma level. In contrast to expectations, longer survival coincided with lower mRNA level in normal colon tissue of the main 8-oxoGua DNA glycosylase, OGG1, but no association was found for PARP-1 expression. When analyzing simultaneously two parameters the discriminating power increased significantly. Combination of low level of urinary 8-oxoGua together with low level of 8-oxodGuo in leukocyte (both below median value) or high concentration of plasma uric acid (above median value) have the best prediction power. Since prediction value of these parameters seems to be comparable to conventional staging procedure, they could possibly be used as markers to predict clinical success in CRC treatment.
机译:这项工作的目的是回答以下问题:描述氧化应激和DNA氧化损伤以及修复的广泛参数是否是结肠癌(CRC)患者生存的适当预后因素?分析了89例CRC患者的以下参数:血浆中尿酸和维生素A,E,C的浓度;白细胞和结肠组织DNA中的8-oxodGuo(8-oxo-7,8-dihydro-2'-deoxyguanosine)水平; 8-oxodGuo和8-oxoGua(8-oxo-7,8-dihydroguanine)的尿排泄率;修复酶OGG1,APE1,ANPG,TDG和PARP1的活性和mRNA或蛋白质水平。使用高效液相色谱(HPLC)或HPLC /气相色谱-质谱技术分析所有DNA修饰和血浆抗氧化剂。通过QPCR,Western或免疫组织化学方法分析修复蛋白的表达。更长的生存期与尿液中的8-oxodGuo / 8oxoGua和DNA的8-oxodGuo含量低以及尿酸血浆浓度高相符。与预期相反,更长的生存期与主要的8-oxoGua DNA糖基化酶OGG1的正常结肠组织中较低的mRNA水平相吻合,但未发现PARP-1表达相关。同时分析两个参数时,判别力显着提高。尿液中低水平的8-oxoGua与低水平的白细胞中的8-oxodGuo(均低于中值)或高浓度血浆尿酸(中值高于)的组合具有最佳预测能力。由于这些参数的预测值似乎与常规分期程序相当,因此它们有可能被用作预测CRC治疗临床成功的标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号